ロード中...
A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions
The JAK2/STAT signaling pathway mediates cytokine receptor signals that are involved in cell growth, survival and homeostasis. JAK2 is a member of the Janus kinase (JAK) family and aberrant JAK2/STAT is involved with various diseases, making the pathway a therapeutic target. The similarity between t...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6288363/ https://ncbi.nlm.nih.gov/pubmed/30564118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01379 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|